A dvances in molecular genetics and stem-cell technology are transforming our understanding of disease. Such progress is desperately needed in amyotrophic lateral sclerosis, a paralysing neurodegenerative disease that is almost uniformly fatal. It is therefore welcome news that three studies (two in this issue 1, 2 and one in Nature Neuro science 3 ) have converged on a molecular mechanism that seems to underlie a familial form of the disease.
Amyotrophic lateral sclerosis (ALS) is typically sporadic, but around 10% of cases are familial. Although mutations in more than a dozen genes can be involved, those in C9ORF72 are by far the most common cause of ALS, being responsible for approximately 40% of familial cases 4 . Mutations in C9ORF72 occur in a section of DNA comprising six tandemly repeated bases: four guanines (G) followed by two cytosines (C). This G 4 C 2 hexanucleotide sequence is typically repeated two or three times, but can be expanded to tens or even thousands of repeats in people with C9ORF72-associated ALS (C9-ALS) 5, 6 . There are two leading models proposing how G 4 C 2 -hexanucleotide-repeat expansion (HRE) leads to neurodegeneration. One, the toxic RNA model, posits that G 4 C 2 RNAs transcribed from the expansion bind to crucial RNA-binding proteins or other cellular factors, which prevents them from functioning normally. The other model proposes that, through an unusual form of translation, these expanded RNA molecules produce toxic dipeptide repeat proteins (DPRs) -such as strings of glycine and arginine (GR) amino acids, or of proline and arginine (PR). Central to both hypotheses is the fact that RNAs harbouring the HRE assemble into G-quadruplex structures that confer abnormal molecular behaviours 7 . There is experimental evidence to support both hypotheses [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] , although it is unclear whether DPRs are expressed at sufficient levels to contribute to toxicity 18 . In the first of the three studies, Zhang et al. that assembles into harmful G-quadruplex structures that can remain in the nucleus or be exported to the cytoplasm. Three studies [1] [2] [3] provide evidence suggesting that the G 4 C 2 HRE RNA may cause cell toxicity in several ways: by binding to target proteins in nuclear-pore complexes in the nucleus, thereby disrupting nuclear export of RNA; by binding to the nuclear-import protein RanGAP outside the nucleus, preventing normal nuclear import; and by undergoing an abnormal form of translation to form toxic dipeptide repeat proteins (DPRs) that interfere with nuclear import, possibly through interactions with karyopherin proteins. Other effects of G 4 C 2 HRE at both the RNA and protein levels remain unclear. and results in a 'rough-eye' trait that can be scored to identify mutations in other genes that lessen or worsen toxicity. Reasoning that proteins that bind to the G 4 C 2 RNA are probably mediators of G 4 C 2 -associated toxicity, the authors crossed flies expressing (G 4 C 2 ) 30 with flies harbouring mutations in genes encoding G 4 C 2 -binding proteins identified through previous biochemical screens 9, 10 . Mutations that activated a gene called RanGAP strongly suppressed rough eye and neurodegeneration in (G 4 C 2 ) 30 flies. The RanGAP protein, which binds to G 4 C 2 RNA, is located on the cytoplasmic face of the nuclear membrane, and is part of one of around 2,000 nuclear-pore complexes that control the flow of proteins and RNA in and out of the nucleus. Zhang and colleagues then identified several other nuclearimport genes involved in (G 4 C 2 ) 30 -elicited neurotoxicity.
Freibaum et al.
2 (page 129) reached similar conclusions using a different strategy. They crossed flies expressing a (G 4 C 2 ) 58 HRE with flies missing defined chromosomal segments spanning from tens of genes to more than a hundred, and, using an iterative approach, homed in on genes whose deletion altered G 4 C 2 toxi city. The authors identified numerous nuclear-import factors whose inactivation worsened the rough-eye trait of (G 4 C 2 ) 58 flies. The comprehensive screen revealed that changes to nuclear-export proteins also enhanced neurodegeneration and rough eye, suggesting that alterations in both nuclear import and export contribute to G 4 C 2 -mediated toxicity, at least in their system. Both groups then probed exactly how G 4 C 2 HREs disrupt nuclear trafficking. Zhang et al. showed that RanGAP bound G 4 C 2 HREs in vitro, and corroborated this finding in vivo using neurons taken from patients with C9-ALS. HRE expression disrupted the nuclear import of fluorescent test substrates and of normal nuclear proteinsmost notably TDP-43, which forms misfolded aggregates in the degenerating motor neurons of most people with ALS. Freibaum and colleagues observed nuclear-membrane irregularities in HRE-expressing cells and demonstrated that G 4 C 2 HREs inhibit nuclear RNA export, an effect that was relieved by reducing the expression of genes that suppressed G 4 C 2 -mediated toxicity. Together, these findings established a strong connection between defective nuclear trafficking and neurodegeneration (Fig. 1) . Do DPRs contribute to G 4 C 2 toxicity? Both studies detected G 4 C 2 -derived DPRs, but neither could show whether these DPRs contributed significantly to toxicity. In the third study discussed here, Jovičić et al. 3 addressed this point directly, performing a genetic screen to identify genes that lessened or worsened the toxicity caused by a PR 50 DPR in the yeast Saccharomyces cerevisiae. Because PR 50 was expressed from synthetic DNA and not from a G 4 C 2 HRE, toxicity should derive from the DPR itself, rather than from its parent RNA. Six of the strongest suppressors of PR 50 -associated toxicity in the researchers' screen encoded members of the karyopherin family of nuclear-import proteins. The screen also suggested that the genesis of ribosomes (the cellular machinery that produces proteins) goes awry in PR 50 -expressing yeast. In the future, even more leads are likely to be mined from these genetic data.
These three studies take us to a higher plane of understanding of C9ORF72-associated ALS, with a focus placed squarely on the nuclear pore. For the future, the newly identified toxicity-suppressing genes will need to be tested in mammalian models of G 4 C 2 expansion and DPR toxicity, probably using recently developed mouse strains 19 . The findings also raise the question of whether nucleartrafficking defects contribute to neurotoxicity in other types of ALS. Neurons have a limited ability to replace damaged nuclear-pore complexes, and age-dependent decreases in nuclear integrity have been postulated as a risk factor for ageing-related disease 20 . Thus, enhancers of nuclear import should be tested in other ALS models, particularly those in which TDP-43 aggregation is observed.
The genetic studies have not resolved whether one mechanism of toxicity predominates in C9-ALS. At face value, the data suggest that G 4 C 2 -containing RNAs and G 4 C 2 -derived DPRs elicit toxicity through an overlapping set of nuclear-pore proteins. However, it remains possible that DPRs contribute to neurotoxicity directly in flies. This question could be answered by investigating whether the nuclearimport enhancers picked up in the G 4 C 2 screens can rescue neurodegeneration in flies expressing toxic DPRs. It will also be important to further characterize G 4 C 2 -RanGAP interactions, and to determine whether DPRs bind nuclear-pore proteins. Finally, because both DPRs and G 4 C 2 HREs reportedly disrupt a subnuclear structure called the nucleolus 10, 13 , the relationship between this mechanism and nuclear-membrane defects should be deciphered.
Can our understanding of toxic G 4 C 2 RNA be leveraged for therapy? Zhang et al. reversed the rough-eye trait by feeding (G 4 C 2 ) 30 flies either a compound that disrupts G 4 C 2 -RanGAP binding or a small-molecule inhibitor of nuclear export. The three studies also identified other genes that may be 'druggable' , including those encoding proteins that oppose RanGAP. Development and preclinical testing of modulators of nuclear import or export is certainly warranted. 
Frictionless fluids from bacterial teamwork
By increasing the sensitivity of an established technique, researchers have shown that swimming bacteria can make frictionless fluids -with potential applications in areas such as microfluidics.
M . C R I ST I N A M A R C H E T T I
T he viscosity of a liquid is a measure of its resistance to flow. In general, denser fluids are more viscous and require more energy to get them to flow through a pipe. Flow with no energy dissipation is a hallmark of exotic states of matter such as superfluidity and superconductivity. Key to these exotic states are quantum effects that dominate at ultralow temperatures -turning liquid helium, for example, into a superfluid that flows without friction through cracks as thin as molecules. Writing in Physi cal Review Letters, López et al. 1 demonstrate that Escherichia coli bacteria swimming in a fluid can organize themselves to counterbalance the energy loss resulting from viscous dissipation and thereby dramatically lower the fluid's viscosity, driving it to vanish or even to become negative.
In 2004, it was predicted 2 that unicellular swimming organisms could substantially change the viscosity of a fluid on the basis of a hydrodynamic theory 3 of active fluids (liquids consisting of self-propelled particles). This suggestion was confirmed by numerical solutions 4, 5 of the theory, which revealed the possibility of vanishing viscosity for suspensions of motile bacteria. Pioneering experiments subsequently confirmed a reduction of viscosity in suspensions of the bacteria Bacillus subtilis 6 and E. coli 7 . A concurrent study 8 demonstrated the sensitivity of this effect to the microscopic cellular-propulsion mechanism by revealing an increase in viscosity for dilute concentrations of the alga Chlamydomonas reinhardtii; however, this behaviour remains puzzling.
Detailed calculations [9] [10] [11] [12] of the response of dilute suspensions of swimmers to an externally imposed shear flow (which induces the velocity profile shown in Fig. 1a) 
